Recent Patents on AntiCancer Drug Discovery
Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
FOR REVIEWERS
CONTENTS & ABSTRACTS
CONTACT US
Monday, January 22, 2018
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 13 Issue 1
1:44 AM
No comments
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 13 Issue 1
Read More
Monday, November 27, 2017
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 4
8:49 PM
No comments
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 4
Read More
Monday, October 16, 2017
Most Citied Article : HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
12:23 AM
No comments
Most Citied Article : HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Read More
Monday, October 9, 2017
Free Trial Request
12:33 AM
No comments
Free Trial Request
Read More
Monday, October 2, 2017
Most Accessed Article : Marine Derived Anticancer Drugs Targeting Microtubule
12:53 AM
No comments
Most Accessed Article : Marine Derived Anticancer Drugs Targeting Microtubule
Read More
Wednesday, September 6, 2017
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 3.
2:57 AM
No comments
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 3.
Read More
Tuesday, September 5, 2017
Most Cited Article: HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
2:30 AM
No comments
Most Cited Article: HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Read More
Tuesday, August 22, 2017
Free Trial Offer
12:09 AM
No comments
Free Trial Offer
Read More
Tuesday, August 15, 2017
Most Accessed Article: HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
12:31 AM
No comments
Most Accessed Article: HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Read More
Sunday, August 6, 2017
Open Access Article: Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
11:51 PM
No comments
Open Access Article: Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Read More
Monday, July 31, 2017
Call For Paper
2:59 AM
No comments
Call For Paper
Read More
Monday, July 17, 2017
Free Trial Request
2:41 AM
No comments
Free Trial Request
Read More
Monday, July 3, 2017
Most Accessed Article:The Warburg Effect and the Hallmarks of Cancer
10:40 PM
No comments
Most Accessed Article:The Warburg Effect and the Hallmarks of Cancer
Read More
Most Accessed Article:Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
10:35 PM
No comments
Most Accessed Article:Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
Read More
Monday, June 12, 2017
Open Access Article: "Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response "
8:44 PM
No comments
Open Access Article: "Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response "
Read More
Tuesday, June 6, 2017
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 2.
4:38 AM
No comments
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 2.
Read More
Sunday, June 4, 2017
Call For Paper
11:12 PM
No comments
Call For Paper
Read More
Sunday, May 28, 2017
Free Trial Request
10:16 PM
No comments
Free Trial Request
Read More
Monday, May 22, 2017
Most Accessed Article: HSP90 Inhibitors:Current Development and Potential in Cancer Therapy
10:56 PM
No comments
Most Accessed Article: HSP90 Inhibitors:Current Development and Potential in Cancer Therapy
Read More
Tuesday, May 9, 2017
Open Access Article: Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens
3:28 AM
No comments
Open Access Article: Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens
Read More
Newer Posts
Older Posts
Home
Social Profiles
Popular
Tags
Blog Archives
New Issue::: Recent Patents on Anti-Cancer Drug Discovery, 11 Issue 1
Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles, and guest edited thematic issues on recent patents ...
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Author(s): Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian LuoPages 184-196 (13) Abst...
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Author(s): Zsuzsanna SubaPages 1-13 (13) Abstract: Background. Results of long-term studies justify that the rate of breast cancer rec...
Highlighted Article: Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conse...
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Author(s): Zsuzsanna SubaPages 154-167 (14) Abstract: Literary data suggest apparently ambiguous interaction between menopausal status...
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 3.
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 3.
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 13 Issue 1
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 13 Issue 1
Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion
Author(s): Sarah Shirley, Alexandre Morizot and Olivier MicheauPages 311-323 (13) Abstract: The use of TRAIL/APO2L and monoclonal anti...
Open Access Article: Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Open Access Article: Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Couple...
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery*
Article Details Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Cou...
Blog Archive
▼
2018
(1)
▼
January
(1)
New Issue Published Recent Patents on Anti-Cancer ...
►
2017
(34)
►
November
(1)
►
October
(3)
►
September
(2)
►
August
(3)
►
July
(4)
►
June
(3)
►
May
(3)
►
April
(3)
►
March
(4)
►
February
(2)
►
January
(6)
►
2016
(22)
►
December
(5)
►
November
(5)
►
October
(7)
►
August
(1)
►
June
(4)
Blogger templates
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion